Ozempic Kidney Trial Sinks Dialysis Stocks - The Wall Street Journal
Oct. 12, 2023, 7:19 p.m.
The weight-loss revolution is shaking another industry.
Kidney-dialysis stocks sank Wednesday after Novo Nordisk (NVO), (DK: NOVO.B) said a trial showed its blockbuster diabetes drug Ozempic could d… [+251 chars]
Leave Comments